Full-Time

Associate Systems Analyst

Confirmed live in the last 24 hours

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Junior, Mid

Hyderabad, Telangana, India

Category
Backend Engineering
Software QA & Testing
Software Engineering
Required Skills
Agile
UI/UX Design
Product Management
JIRA
SCRUM
Development Operations (DevOps)
Requirements
  • Master’s degree and 1 to 3 years of Life Science/Biotechnology/Pharmacology/Information Systems experience  OR
  • Bachelor’s degree and 3 to 5 years of Life Science/Biotechnology/Pharmacology/Information Systems experience OR
  • Diploma and 7 to 9 years of Life Science/Biotechnology/Pharmacology/Information Systems experience
  • Experience with Agile software development methodologies (Scrum)
  • Excellent communication skills and the ability to collaborate with senior leadership with confidence and clarity
  • Experience in writing requirements for development of modern web application
  • Experience of DevOps, Continuous Integration and Continuous Delivery methodology
  • Has experience with writing user requirements and acceptance criteria in agile project management systems like JIRA.
Responsibilities
  • Collaborate with System Architects and Product owners to manage business analysis activities, ensuring alignment with engineering and product goals.
  • Capture the voice of the customer to define business processes and product needs.
  • Work with Product Owners and customers to define scope and value for new developments.
  • Collaborate with Engineering, testing teams as well as Product Management to prioritize release scopes and groom the Product backlog.
  • Facilitate the breakdown of Epics into Features and Sprint-Sized User Stories and participate in backlog reviews with the development team.
  • Clearly express features in User Stories/requirements so all team members and collaborators understand how they fit into the product backlog.
  • Maintain and ensure the quality of documented user stories/requirements in tools such as Jira.
  • Ensure Acceptance Criteria and Definition of Done are well-defined.
  • Work closely with UX to align technical requirements, scenarios, and business process maps with User Experience designs.
  • Validate that test scenarios meet feature acceptance criteria and customer expectations.
  • Stay focused on software development to ensure it meets requirements, providing proactive feedback to collaborators.
  • Develop and implement effective product demonstrations for internal and external collaborators.
Desired Qualifications
  • Familiarity with GxP, CFR 21 Part 11 and systems validation
  • Experience in creating and executing validation protocols (e.g., Installation Qualification (IQ), Operational Qualification (OQ))
  • Experience with testing and validation tools, and testing frameworks
  • Experience as a business analyst, with command of business analysis techniques & tools, as well as SDLC & iterative systems development methodologies
  • SAFe for Teams certification (preferred)
  • Certified Business Analysis Professional (CBAP) (preferred)

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are derived from living organisms, to address conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's products work by utilizing biological processes to create effective treatments for patients. Unlike many competitors, Amgen emphasizes a strong commitment to research and development, reinvesting a large portion of its earnings to discover new therapies. The goal of Amgen is to improve patient care and outcomes by providing effective therapeutic solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Amgen's investment in AI aligns with trends in biotechnology innovation.
  • Institutional investments indicate strong market confidence in Amgen's growth.
  • FTC clearance of the Horizon merger may ease future regulatory hurdles.

What critics are saying

  • Competitors' AI-driven drug discovery could outpace Amgen's traditional R&D methods.
  • FTC scrutiny of mergers may complicate Amgen's future growth strategy.
  • Advancements in quantum technologies could pose a competitive threat to Amgen.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline of potential new therapies in development.
  • Amgen's acquisition of Horizon Therapeutics enhances its rare disease portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.

BioSpace
Sep 19th, 2023
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans

The consent agreement struck between the FTC and Amgen and Horizon Therapeutics could have significant implications for ongoing and future M&A challenges, experts told BioSpace.